Cargando…
Drug-induced alopecia after dupilumab therapy
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289959/ https://www.ncbi.nlm.nih.gov/pubmed/30560185 http://dx.doi.org/10.1016/j.jdcr.2018.10.010 |
| _version_ | 1783379999700549632 |
|---|---|
| author | Flanagan, Kathleen Sperling, Leonard Lin, Janet |
| author_facet | Flanagan, Kathleen Sperling, Leonard Lin, Janet |
| author_sort | Flanagan, Kathleen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6289959 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-62899592018-12-17 Drug-induced alopecia after dupilumab therapy Flanagan, Kathleen Sperling, Leonard Lin, Janet JAAD Case Rep Case Report Elsevier 2018-12-06 /pmc/articles/PMC6289959/ /pubmed/30560185 http://dx.doi.org/10.1016/j.jdcr.2018.10.010 Text en © 2018 Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Case Report Flanagan, Kathleen Sperling, Leonard Lin, Janet Drug-induced alopecia after dupilumab therapy |
| title | Drug-induced alopecia after dupilumab therapy |
| title_full | Drug-induced alopecia after dupilumab therapy |
| title_fullStr | Drug-induced alopecia after dupilumab therapy |
| title_full_unstemmed | Drug-induced alopecia after dupilumab therapy |
| title_short | Drug-induced alopecia after dupilumab therapy |
| title_sort | drug-induced alopecia after dupilumab therapy |
| topic | Case Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289959/ https://www.ncbi.nlm.nih.gov/pubmed/30560185 http://dx.doi.org/10.1016/j.jdcr.2018.10.010 |
| work_keys_str_mv | AT flanagankathleen druginducedalopeciaafterdupilumabtherapy AT sperlingleonard druginducedalopeciaafterdupilumabtherapy AT linjanet druginducedalopeciaafterdupilumabtherapy |